Oct 09, 2015 8:30am EDT

Adaptimmune Growth Leads to Long-Term Expansion Plans in Philadelphia

Oct 07, 2015 9:14am EDT

Adaptimmune to Report Full Fiscal Year 2015 Financial Results on October 13, 2015

Oct 06, 2015 7:00am EDT

Adaptimmune Announces New Research and Development Facility in Oxfordshire

Sep 28, 2015 8:00am EDT

Adaptimmune to Participate in the Leerink Partners Inaugural Immuno-Oncology Roundtable

Sep 14, 2015 3:22pm EDT

Adaptimmune to Participate in Two Upcoming Investor Conferences

Sep 09, 2015 8:30am EDT

Adaptimmune Announces Expansion of Senior Team to Augment Clinical Expertise and Support Growth

Sep 03, 2015 8:45am EDT

Adaptimmune to Participate in the 22nd Annual BioCentury 'NewsMakers in the Biotech Industry' Conference

Sep 01, 2015 7:30am EDT

Adaptimmune Expands Trial of T-cell Therapy for Synovial Sarcoma and Achieves Clinical Milestones

Aug 04, 2015 8:00am EDT

Adaptimmune to Participate in the Wedbush 2015 Life Sciences Conference

Jul 20, 2015 11:01am EDT

Adaptimmune's NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence, Clinical Activity and Tolerability in Clinical Study in Multiple Myeloma Patients